Skip to content

Study on the application of Chinese medicine directional dialysis in elderly patients with diabetic high-risk feet with Qi deficiency and blood evidence

Study on the application of Chinese medicine directional dialysis in elderly patients with diabetic high-risk feet with Qi deficiency and blood evidence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001073
Enrollment
Unknown
Registered
2025-05-28
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot

Interventions

intervention group:Every day at the sixth hour (9:00) for directional drug delivery therapy, acupoints selected foot Sanli, Sanyinjiao, Yinlingquan, the frequency of once a day, each time 30 minutes.
control group:Routine treatment: patients are instructed to take routine medication according to the Chinese Guidelines for the Prevention and Control of Type 2 Diabetes Mellitus (2019 edition). Condu

Sponsors

Shanghai Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) patients with a clear history of type 2 diabetes mellitus with a disease duration of =10 years and EMG consistent with the IWGDF diagnosis of diabetic high-risk foot; (2) those who met the above diagnostic criteria for Western medicine diagnosis and traditional Chinese medicine evidence; (3) those who were aged =60 years and had no wounds or skin diseases on both lower limbs; and (4) patients who gave informed consent to the study and had signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) patients with peripheral neuropathy caused by other reasons; (2) patients with acute diseases such as acute cerebral hemorrhage; (3) patients with mental illnesses who cannot cooperate with the examination and treatment and patients with infectious diseases; (4) patients with cardiac pacemakers and metal implants in the body; (5) pregnant women; (6) patients who are allergic to the traditional Chinese medicine components in the directional transdermal medicines used and those who have severe allergies; (7) patients with a tendency to hemorrhage and bleeding disorders; and (8) patients who have a tendency to hemorrhage and bleeding disorders. (7) Patients with bleeding tendency and bleeding disorders.

Design outcomes

Primary

MeasureTime frame
Temperature controlled blood flow;Chinese Medicine Criteria Score;

Secondary

MeasureTime frame
Toronto clinical scoring system;nerve conduction velocity;ankle-brachial index (ABI);vibration threshold;

Countries

China

Contacts

Public ContactLifang Ma

Shanghai Seventh People's Hospital

2169336263@qq.com+86 192 6581 6211

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026